Literature DB >> 10756072

Preferential expression of myelencephalon-specific protease by oligodendrocytes of the adult rat spinal cord white matter.

I A Scarisbrick1, K Asakura, S Blaber, M Blaber, P J Isackson, T Bieto, M Rodriguez, A J Windebank.   

Abstract

Myelencephalon-specific protease (MSP) is a novel serine protease that is expressed predominantly in the nervous system. In the adult rat spinal cord, MSP mRNA expression was dramatically upregulated, in both the white and gray matter, after systemic exposure to the glutamate receptor agonist, kainic acid (KA) (Scarisbrick et al. J Neurosci 17: 8156-8168, 1997b). To determine the cell-specific expression patterns of MSP, we generated MSP-specific monoclonal antibodies. These have been used in immunohistochemical and in situ hybridization colocalization studies, to demonstrate that MSP mRNA and protein are produced predominantly by CNP-immunoreactive oligodendroglia, but not by GFAP-immunoreactive astrocytes, in the white matter of the normal adult cord. In vitro, the soma of oligodendrocytes were also densely MSP immunoreactive, as were their growth tips, while astrocytes were associated with lower levels. These findings suggest that the enzymatic activity of MSP is likely to be important in the biology of oligodendrocytes and/or in the maintenance of the nerve fiber tracts of the adult spinal cord. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756072     DOI: 10.1002/(sici)1098-1136(200005)30:3<219::aid-glia2>3.0.co;2-2

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  13 in total

1.  Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.

Authors:  Isobel A Scarisbrick; Maja Radulovic; Joshua E Burda; Nadya Larson; Sachiko I Blaber; Caterina Giannini; Michael Blaber; Alexander G Vandell
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

2.  Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.

Authors:  Michael Panos; George P Christophi; Moses Rodriguez; Isobel A Scarisbrick
Journal:  Biol Chem       Date:  2014-09       Impact factor: 3.915

3.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

4.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

5.  Protease activated receptor 2 controls myelin development, resiliency and repair.

Authors:  Hyesook Yoon; Maja Radulovic; Grant Walters; Alex R Paulsen; Kristen Drucker; Phillip Starski; Jianmin Wu; David P Fairlie; Isobel A Scarisbrick
Journal:  Glia       Date:  2017-09-18       Impact factor: 7.452

6.  Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis.

Authors:  Hyesook Yoon; Isobel A Scarisbrick
Journal:  Biol Chem       Date:  2016-12-01       Impact factor: 3.915

7.  Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms.

Authors:  Hyesook Yoon; Maja Radulovic; Isobel A Scarisbrick
Journal:  Biol Chem       Date:  2018-09-25       Impact factor: 3.915

8.  Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.

Authors:  Alexander G Vandell; Nadya Larson; Gurunathan Laxmikanthan; Michael Panos; Sachiko I Blaber; Michael Blaber; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2008-09-06       Impact factor: 5.372

9.  Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.

Authors:  Hyesook Yoon; Maja Radulovic; Jianmin Wu; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neurochem       Date:  2013-05-27       Impact factor: 5.372

10.  Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma.

Authors:  Kristen L Drucker; Alex R Paulsen; Caterina Giannini; Paul A Decker; Sachiko I Blaber; Michael Blaber; Joon H Uhm; Brian P O'Neill; Robert B Jenkins; Isobel A Scarisbrick
Journal:  Neuro Oncol       Date:  2013-01-10       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.